S100A9 and chronic obstructive pulmonary disease: Immunohistochemistry localized S100A9 predominantly to alveolar/airway fibroblasts and immune cells in COPD mice, with elevated expression confirmed in smoke‐exposed models (Figures 3J and S8E), consistent with a previous study [18].